Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
12.98 USD | +2.29% | -0.99% | -5.12% |
14.01. | Sotera Health Company strebt Fusionen und Übernahmen an | CI |
14.01. | Sotera Health Company Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 08:15 AM |
Voraussichtliche Gewinn- und Verlustrechnung: Sotera Health Company
Steuerjahr: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Umsatz 1 | 778.3 | 818.2 | 931.5 | 1’004 | 1’049 | 1’101 | 1’158 | 1’230 |
Veränderung | - | 5.12% | 13.85% | 7.75% | 4.54% | 4.92% | 5.21% | 6.22% |
EBITDA 1 | - | 419.9 | 481.2 | 506.2 | 528 | 547.7 | 581.2 | 621.5 |
Veränderung | - | - | 14.62% | 5.2% | 4.3% | 3.73% | 6.12% | 6.93% |
Betriebsergebnis (EBIT) 1 | - | 356.6 | 417.1 | 442.2 | 451.5 | 457.7 | 491.3 | 526.3 |
Veränderung | - | - | 16.97% | 6.04% | 2.08% | 1.37% | 7.35% | 7.12% |
Gezahlte Zinsen 1 | - | -215.3 | -74.19 | -80.14 | -142.9 | -165.5 | -160.3 | -149.7 |
Gewinn vor Steuern (EBT) 1 | - | -38.86 | 175.7 | - | - | 112.8 | 145.2 | 181.8 |
Veränderung | - | - | - | -100% | - | - | 28.77% | 25.23% |
Nettoergebnis 1 | -20.85 | -38.62 | 116.9 | -233.6 | 51.38 | 64.97 | 128.4 | 157.4 |
Veränderung | - | 85.21% | - | - | - | 26.45% | 97.7% | 22.59% |
Datum der Veröffentlichung | 02.09.20 | 09.03.21 | 01.03.22 | 28.02.23 | 27.02.24 | - | - | - |
Vorläufige Bilanz: Sotera Health Company
Steuerjahr: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Nettoverschuldung 1 | - | 1’758 | 1’679 | 1’626 | 2’005 | 1’862 | 1’693 | 1’455 |
Veränderung | - | - | -4.49% | -3.16% | 23.31% | -7.11% | -9.08% | -14.06% |
Datum der Veröffentlichung | 02.09.20 | 09.03.21 | 01.03.22 | 28.02.23 | 27.02.24 | - | - | - |
Prognostizierter Cashflow: Sotera Health Company
Steuerjahr: Dezember | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
CAPEX Investitionsaufwand 1 | 53.51 | 102.2 | 182.4 | 215 | 170.5 | 202.7 | 162.3 |
Veränderung | - | 90.93% | 78.52% | 17.87% | -20.69% | 18.87% | -19.9% |
Free Cashflow (FCF) 1 | 67.08 | 179.4 | 95.58 | -362.7 | 215 | 182.5 | 265 |
Veränderung | - | 167.42% | -46.72% | -479.47% | -159.28% | -15.12% | 45.21% |
Datum der Veröffentlichung | 09.03.21 | 01.03.22 | 28.02.23 | 27.02.24 | - | - | - |
Voraussichtliche Finanzkennzahlen: Sotera Health Company
Steuerjahr: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Rentabilität | ||||||||
EBITDA-Marge (%) | - | 51.32% | 51.66% | 50.44% | 50.32% | 49.75% | 50.18% | 50.52% |
EBIT-Marge (%) | - | 43.58% | 44.77% | 44.06% | 43.02% | 41.57% | 42.42% | 42.78% |
EBT-Marge (%) | - | -4.75% | 18.86% | - | - | 10.24% | 12.54% | 14.78% |
Nettogewinn (%) | -2.68% | -4.72% | 12.55% | -23.27% | 4.9% | 5.9% | 11.09% | 12.8% |
FCF-Marge N (%) | - | 8.2% | 19.26% | 9.52% | -34.57% | 19.53% | 15.76% | 21.54% |
FCF / Nettogewinn (%) | - | -173.7% | 153.47% | -40.92% | -705.99% | 330.94% | 142.09% | 168.31% |
Rentabilität | ||||||||
ROA | - | 3.71% | 8.86% | 9.15% | 7.37% | 8.05% | 8.74% | 9.55% |
ROE | - | - | 47.34% | 57.72% | 57.97% | 41.19% | 36.93% | 32.52% |
Finanzielle Gesundheit | ||||||||
Verschuldungsgrad (Verbindlichkeiten/EBITDA) | - | 4.19x | 3.49x | 3.21x | 3.8x | 3.4x | 2.91x | 2.34x |
Verschuldung / Free Cashflow | - | 26.22x | 9.36x | 17.01x | -5.53x | 8.66x | 9.28x | 5.49x |
Kapitalintensität | ||||||||
CAPEX / Umsatz (%) | - | 6.54% | 10.97% | 18.17% | 20.49% | 15.49% | 17.5% | 13.19% |
CAPEX / EBITDA (%) | - | 12.74% | 21.23% | 36.03% | 40.71% | 31.13% | 34.87% | 26.12% |
CAPEX / FCF (%) | - | 79.77% | 56.95% | 190.81% | -59.27% | 79.3% | 111.05% | 61.26% |
Elemente pro Aktie | ||||||||
Cashflow pro Aktie 1 | - | 0.5073 | 0.3657 | - | - | - | - | - |
Veränderung | - | - | -27.91% | - | - | - | - | - |
Dividende pro Aktie 1 | - | - | - | - | - | - | - | - |
Veränderung | - | - | - | - | - | - | - | - |
Buchwert je Aktie 1 | - | 1.903 | 2.071 | 1.24 | 1.569 | 1.808 | 2.372 | 3.072 |
Veränderung | - | - | 8.84% | -40.12% | 26.52% | 15.21% | 31.21% | 29.5% |
Gewinn pro Aktie 1 | - | -0.16 | 0.41 | -0.83 | 0.18 | 0.2267 | 0.45 | 0.5467 |
Veränderung | - | - | -356.25% | -302.44% | -121.69% | 25.93% | 98.53% | 21.48% |
Anz. der Aktien (in Tausend) | - | 284’321 | 282’917 | 282’113 | 282’623 | 283’239 | 283’239 | 283’239 |
Datum der Veröffentlichung | - | 09.03.21 | 01.03.22 | 28.02.23 | 27.02.24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
KGV | 57.3x | 28.8x |
KBV | 7.18x | 5.47x |
EV / Sales | 5.03x | 4.64x |
Rendite | - | - |
Gewinn pro Aktie & Dividende
Historische Entwicklung KGV
Entwicklung der Dividendenrendite
Quartalsumsätze - Abweichungsrate
- Börse
- Aktien
- A2QHA5 Aktie
- Finanzen Sotera Health Company
MarketScreener is also available in this country: United States.
Switch edition